Point of Care Significance 5/10

Routine ophthalmology referral not indicated for all newborns with congenital CMV from screening

Investigators reviewed ophthalmology examination records for 347 infants with congenital cytomegalovirus (cCMV) identified through a population-based newborn dried blood spot screening program in Ontario, Canada. Only two infants with symptomatic cCMV exhibited cCMV-related chorioretinal scars, representing 0.58% of all screening-positive infants and 3.9% of symptomatic cases, while no asymptomatic infants showed ocular pathology. The study reports that routine ophthalmology examinations for every newborn with cCMV detected on screening rarely yield clinically actionable findings, suggesting that laboratory directors and pediatricians should adopt risk-based referral criteria rather than universal eye exams.

The original study

Eye Findings Following Congenital Cytomegalovirus Newborn Screening.

Authors
Leahy KE, Dunn JKE, Gallagher L, Reuvers E, Chakraborty P, Bitnun A, et al.
Journal
Pediatrics
Type
Journal Article
PMID
42764171
Read the original study →

Original abstract

BACKGROUND AND OBJECTIVE: Consensus guidelines have recommended eye examinations for all newborns with congenital cytomegalovirus (cCMV) infection; however, structured ophthalmic examinations are seldom reported. Existing literature suggests ocular pathology is uncommon in cCMV, particularly asymptomatic cCMV. We aimed to assess utility of ophthalmology examination in every infant with cCMV identified on newborn screening and whether alternative, risk-based strategies should be considered. DESIGN: Eye examination records were reviewed for infants who screened positive for cCMV from routinely collected newborn dried blood spot between July 2019 and January 2022 in Ontario, Canada. Prevalence of cCMV-related ophthalmic findings in infants with symptomatic and asymptomatic cCMV infection was evaluated. RESULTS: Of 394 infants who screened positive for cCMV, 347 (88.1%) had eye examinations; of these, 51 (14.7%) had symptomatic cCMV. Two infants with symptomatic cCMV had unilateral chorioretinal scars attributable to cCMV, constituting 0.58% of CMV-positive infants and 3.9% of infants with symptomatic cCMV. Both infants were referred to ophthalmology with clinically diagnosed cCMV with significant systemic manifestations, before their CMV screening results were known. No infant with asymptomatic infection had CMV-related ocular findings. CONCLUSIONS: Eye abnormalities attributable to cCMV were rarely identified through this large, population-based screening program and were not found in infants with asymptomatic cCMV. This suggests eye examination for every newborn with cCMV detected on screening is not routinely indicated. Alternative criteria for ophthalmology referral may be considered, such as infants with symptomatic cCMV and those with coexisting features their physician deems relevant.